Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Editor-in-Chief: Dr Roger M Pinder

1176-6328 (Print) - went to online only in 2009

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Articles:

Latest articles:

- 5 records -

Letter

Role of Exogenous Neuregulin-1 as a Therapeutic Agent in Focal Epilepsy [Letter]

Gul O, Khalid M, Gul S

Neuropsychiatric Disease and Treatment 2024, 20:1117-1118

Published Date: 17 May 2024

Study Protocol

Comparison of Effects of Propofol Combined with Different Doses of Esketamine for ECT in the Treatment of Depression: A Randomized Controlled Trial Protocol

Chen X, Zhou R, Lan L, Zhu L, Chen C, Zhang X, Han J, Xia L

Neuropsychiatric Disease and Treatment 2024, 20:1107-1115

Published Date: 17 May 2024

Clinical Trial Report

Impact of Mobile Neurofeedback on Internet Addiction and Neurocognitive Function in Neurotypical Children: Double-Blind, Sham-Controlled Randomized Clinical Trial

Choi JW, Yang S, Kim JW

Neuropsychiatric Disease and Treatment 2024, 20:1097-1106

Published Date: 17 May 2024

Original Research

Evaluation of Depression and Its Correlates in Terms of Demographics, Eating Habits, and Exercises Among University Students: A Multicenter Cross-Sectional Analysis

Zheng H, Li C, Zhang L, Wang T, Cai Z, Lei M

Neuropsychiatric Disease and Treatment 2024, 20:1079-1095

Published Date: 17 May 2024

Original Research

CBF Profile in Computed Tomography Perfusion-Based AutoMIStar Software Predicts Futile Recanalization After Basilar Artery Thrombectomy

Wang Z, Ji K, Fang Q

Neuropsychiatric Disease and Treatment 2024, 20:1065-1077

Published Date: 16 May 2024